SPPCP Conference - Society of Pain & Palliative Care Pharmacists Conference
The Mentorship Model: Cultivating Resilience and Leadership in Palliative Care Pharmacy
May 22nd 2025At the 2025 SPPCP Virtual Conference, Carolyn Hall, PharmD, BCPS, and Maria Felton Lowry, PharmD, BCPS, BCGP, presented a comprehensive and practical framework for pharmacy professionals to build effective, adaptable mentorship relationships.
Managing Opioid Complexity: The Role of Pharmacists in OUD and C-POD Care
May 21st 2025In a session at the 2025 Virtual Conference on Pain and Palliative Care, Isabella Zerfas, PharmD, and Abbey Galligan, PharmD, BCPS, explore effective pain management strategies for opioid use disorder (OUD) and complex persistent opioid dependence.
Can Low-Dose Naltrexone Fill the Gaps in Palliative Pain Management?
May 12th 2025Emma Murter, PharmD, MPH, and Madison N. Irwin, PharmD, BCPS, discuss the potential role of low-dose naltrexone in managing chronic pain in palliative care, highlighting its anti-inflammatory properties, limited adverse effects, and current evidence gaps—particularly in comparison to traditional opioids and adjuvant analgesics.
Psilocybin at the Crossroads: Regulatory Barriers and the Pharmacist’s Role in Palliative Innovation
May 6th 2025Abigail Thomas, PharmD, and Lee A. Kral, PharmD, discuss the evolving role of psilocybin-assisted therapy in palliative care, highlighting current evidence, safety concerns, and how pharmacists can guide patient selection, manage drug interactions, and support education as the therapy moves closer to clinical use.
Pharmacist-Led Care in Palliative Settings: Using Anticholinergics Thoughtfully and Compassionately
May 5th 2025Diana Violanti, PharmD, and Pamela S. Moore, PharmD, BCGP, discuss the nuanced use of anticholinergic agents for managing terminal secretions at end of life, highlighting practical considerations, timing, safety concerns such as delirium, and the limited yet evolving evidence supporting their role in palliative care.
